UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,836,892 shares of the medical device company’s stock after buying an additional 18,282 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Cooper Companies were worth $168,865,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Covestor Ltd raised its position in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after acquiring an additional 120 shares in the last quarter. Shell Asset Management Co. increased its holdings in shares of Cooper Companies by 15.5% in the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company’s stock valued at $87,000 after purchasing an additional 127 shares during the period. Torray Investment Partners LLC grew its holdings in Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after acquiring an additional 132 shares during the period. Mather Group LLC. grew its holdings in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares during the period. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

COO has been the topic of a number of recent research reports. JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday. BNP Paribas upgraded Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research report on Wednesday. Finally, Robert W. Baird cut their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Stock Down 0.1%

Cooper Companies stock opened at $79.30 on Friday. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The stock has a 50 day moving average of $80.28 and a two-hundred day moving average of $89.52. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $15.86 billion, a price-to-earnings ratio of 40.67, a PEG ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.